Assembly Biosciences

$5.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.11 (-1.95%) Today
-$0.23 (-4.16%) As of 1:24 PM UTC after-hours

Why Robinhood?

You can buy or sell ASMB and other stocks, options, and ETFs commission-free!

About ASMB

Assembly Biosciences, Inc. Common Stock, also called Assembly Biosciences, is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA. The listed name for ASMB is Assembly Biosciences, Inc. Common Stock.

CEO
John G. McHutchison
Employees
115
Headquarters
South San Francisco, California
Founded
2005
Market Cap
176.79M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.93M
High Today
$5.83
Low Today
$5.41
Open Price
$5.65
Volume
2.51M
52 Week High
$27.84
52 Week Low
$4.78

ASMB Earnings

-$1.15
-$0.70
-$0.26
$0.19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Apr 5, After Hours

You May Also Like

GWGH
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure